• 薬物動態解析プラットフォームDruMAPの開発Development of DruMAP, a Drug Metabolism and Pharmacokinetics Analysis Platform

詳細は下記のリンクよりごらんいただけます。

• Development of DruMAP, Drug Metabolism and pharmacokinetics Analysis Platform
• Development of in silico prediction models to evaluate pharmacokinetic profiles using chemical structure information

詳細は下記のリンクよりごらんいただけます。

• P5-06 (Development of a pharmacokinetics prediction system using multiscale integrated modeling: 13. Development of DruMAP, Drug Metabolism and pharmacokinetics Analysis Platform)
• P5-07 (Development of a pharmacokinetics prediction system using multiscale integrated modeling: 14. In silico three-class predictor of human intestinal absorption with Caco-2 permeability and dried-DMSO solubility)
• P5-08 (Development of a pharmacokinetics prediction system using multiscale integrated modeling:15. Development of an in silico prediction system of human renal excretion and clearance from chemical structure information)
• P6-09 (Computational drug target prediction using PU learning approach)

詳細は下記のリンクよりごらんいただけます。

4件のポスター発表を行いました（敬称略）。

• F-13: Prediction of pharmacokinetic profiles using chemical structure information: Fraction unbound in plasma and renal excretion（担当・渡邉）
• F-15: Development of DruMAP, Drug Metabolism and pharmacokinetics Analysis Platform（担当・川島）
• L-43: A study of gut microbial variations associated with phenotypic metadata in a healthy Japanese population（担当・朴）
• V-123: Pentachlorophenol affects RIG-1 antiviral pathway that produces type I interferon at the transcriptional level（担当・夏目）

詳細は下記のリンクよりごらんいただけます。